485 related articles for article (PubMed ID: 11464650)
21. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.
Van Tellingen A; Grooteman MP; Bartels PC; Van Limbeek J; Van Guldener C; Wee PM; Nubé MJ
Kidney Int; 2001 Jan; 59(1):342-7. PubMed ID: 11135089
[TBL] [Abstract][Full Text] [Related]
22. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
23. [Hyperhomocysteinemia and alternate vitamin supplementation].
De Angelis S; Noce A; Dessì M; Pastore A; Scaccia F; Trombetta M; Tozzo C; Splendiani G
G Ital Nefrol; 2007; 24(1):51-5. PubMed ID: 17342693
[TBL] [Abstract][Full Text] [Related]
24. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Righetti M; Serbelloni P; Milani S; Ferrario G
Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
[TBL] [Abstract][Full Text] [Related]
26. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
27. B-vitamins and homocysteine in Spanish institutionalized elderly.
Gonzalez-Gross M; Sola R; Albers U; Barrios L; Alder M; Castillo MJ; Pietrzik K
Int J Vitam Nutr Res; 2007 Jan; 77(1):22-33. PubMed ID: 17685092
[TBL] [Abstract][Full Text] [Related]
28. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
[TBL] [Abstract][Full Text] [Related]
29. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
30. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
[TBL] [Abstract][Full Text] [Related]
31. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
32. Plasma homocysteine concentration changes after renal transplantation in children.
Merouani A; Delvin EE; Genest J; Rozen R; Lambert M
Pediatr Nephrol; 2002 Jul; 17(7):520-3. PubMed ID: 12172766
[TBL] [Abstract][Full Text] [Related]
33. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.
Chiarello PG; Vannucchi MT; Moysés Neto M; Vannucchi H
Int J Vitam Nutr Res; 2003 Nov; 73(6):431-8. PubMed ID: 14743547
[TBL] [Abstract][Full Text] [Related]
34. Folate and cobalamin synergistically decrease the risk of high plasma homocysteine in a nonsupplemented elderly institutionalized population.
Huerta JM; González S; Vigil E; Prada M; San Martín J; Fernández S; Patterson AM; Lasheras C
Clin Biochem; 2004 Oct; 37(10):904-10. PubMed ID: 15369722
[TBL] [Abstract][Full Text] [Related]
35. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
[TBL] [Abstract][Full Text] [Related]
37. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
[TBL] [Abstract][Full Text] [Related]
38. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
39. Neither folic nor folinic acid normalize homocysteine levels in hemodialysis patients.
Armada E; Pérez C; Otero A; Esteban J; Camba M; Gayoso P; Suárez D
Clin Nephrol; 2003 Sep; 60(3):168-75. PubMed ID: 14524579
[TBL] [Abstract][Full Text] [Related]
40. Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency.
Lindner A; Bankson DD; Stehman-Breen C; Mahuren JD; Coburn SP
Am J Kidney Dis; 2002 Jan; 39(1):134-45. PubMed ID: 11774112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
